Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs Metformin vs Combination in T2DM With CAD
ChiCTR-IPR-16008578Phase 4Completed
- Sponsor
- Tianjin First Central Hospital
- Start
- Apr 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of liraglutide and metformin in type 2 diabetes mellitus (T2DM) and coronary arteriosclerosis (4 arms), sponsored by Tianjin First Central Hospital. Primary endpoints: blood pressure, blood glucose and 9 more. Started Apr 2012; status: completed.
02
Drugs
liraglutidemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-16008578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008578.